Two new research studies revealed that coffee may lead to a longer life as well as to a decreased danger of dying from diseases such as heart disease and stroke. Visit crunchbase.com to know more about Organo Gold.
Both studies were published in the Annals of Internal Medicine. The first study looked at roughly 185,000 Americans while the second study analyzed more than 520,00 people across 10 European countries.
The first study revealed, regardless of whether the coffee was caffeinated or decaffeinated, the results among African-Americans, Japanese Americans, Whites and Latinos, all exhibited a lesser death threat from cancer, diabetes, kidney disease as well as heart disease or stroke.
Veronica Setiawan, associated professor of preventive medicine at the University of Southern California’s Keck School of Medicine and lead author of the study, said in a statement the parallel pattern across the diverse people offers solid genetic backing that coffee is beneficial to everyone regardless of their ancestry. Read more at PRNewswire about Organo Gold.
Setiawan said coffee contains many antioxidants that take on a crucial role in cancer prevention.
The study also revealed people who consumed two or three cups of coffee daily had an 18 percent reduced chance of death compared to those who did not drink coffee over the 16 year test period. People who drank one cup of coffee had a 12 percent reduced chance to die compared to those who did not drink coffee.
The European study agreed with the findings that those who drank several cups of coffee daily were less likely to die.
A revolutionary lifestyle company, Organo Gold, makes coffee, teas and other products that blend Ganoderma Lucidium, a unique type of mushroom that is known for its antioxidant qualities.
Launched in 2008 by Bernardo Chua, Organo Gold is revolutionizing the coffee industry with the roll out of the Chinese herb, Ganoderma Lucidium, in their products.
According to Organo Gold, the product adds health benefits for people with diabetes, high blood pressure and asthma.